Vertebroplasty for osteoporotic compression fractures: current practice and evolving techniques.
Perutaneous vertebroplasty was developed in France by Deramond et al., who provided initial reports of the procedure in 1987. This minimally invasive procedure uses a large-bore bone-cutting needle to percutaneously access a vertebral body, inject bone cement, and thereby stabilize and reinforce the remaining bone structure. The procedure was used initially to treat aggressive hemangiomas, but it then was extended to the treatment of osteolytic metastases and myeloma and currently osteoporotic compression fractures refractory to medical therapy. In this article, we review the current technique and its indications along with emerging devices and areas of current research.
Peters
Kieth R
KR
Institute for Spine Care, Chicago Institute of Neurosurgery and Neuroresearch, Chicago, Illinois, USA.
Guiot
Bernard H
BH
Martin
Pamela A
PA
Fessler
Richard G
RG
D000368:Aged; D000369:Aged, 80 and over; D001843:Bone Cements / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures / Q000009:adverse effects; D019635:Neurosurgical Procedures / Q000009:adverse effects / Q000639:trends; D010024:Osteoporosis / Q000150:complications*; D010146:Pain / Q000139:chemically induced / Q000503:physiopathology; D010147:Pain Measurement; D019904:Polymethyl Methacrylate / Q000009:adverse effects / Q000627:therapeutic use; D016103:Spinal Fractures / Q000209:etiology* / Q000503:physiopathology / Q000601:surgery*; D013131:Spine / Q000601:surgery*; D016896:Treatment Outcome
D001843:Bone Cements; D019904:Polymethyl Methacrylate